Document Detail


Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
MedLine Citation:
PMID:  20956995     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The objective was to test the hypothesis that in patients with prostate cancer undergoing radical prostatectomy (RP), diabetic patients are at a higher risk of harboring a high-grade tumor than non-diabetic patients. We examined 2060 consecutive men who underwent RP between 2001 and 2009. Of them, 7.1% had type 2 diabetes mellitus (DM). A high-grade tumor was defined as having a Gleason score 8. Univariable and multivariable logistic regression analyses were used to test the relationship between type 2 DM and high-grade tumor. Mean patient age was 64 years (range: 45-85). Mean total PSA level was 9 ng ml(-1) (range: 1-89.5). A significantly higher percentage of diabetic patients had high-grade tumor on biopsy (16.3 vs 7.6%; P=0.001) and on RP specimen (21.1 vs 11.7%; P=0.001) in comparison with non-diabetic patients. In multivariable analyses, DM was an independent predictor of high-grade tumor on biopsy (odds ratio=2.31, P=0.001) and on final pathological specimen (odds ratio=2.22, P=0.002). In patients undergoing RP, those with type 2 DM had a higher risk of harboring a poorly differentiated tumor on final pathological examination.
Authors:
F Abdollah; A Briganti; N Suardi; A Gallina; U Capitanio; A Salonia; A Cestari; G Guazzoni; P Rigatti; F Montorsi
Related Documents :
16875755 - Fasting cut-points in determining prevalence of diabetes in an arab population of the m...
16274775 - Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in ...
20852505 - Prevalence of diabetic foot syndrome and its risk factors in the uk.
17098085 - Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: foll...
8013905 - Altered regulatory responses to glucose are associated with a glucose transport defect ...
21680995 - Clinical interpretation of indices of quality of glycemic control and glycemic variabil...
Publication Detail:
Type:  Journal Article     Date:  2010-10-19
Journal Detail:
Title:  Prostate cancer and prostatic diseases     Volume:  14     ISSN:  1476-5608     ISO Abbreviation:  Prostate Cancer Prostatic Dis.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815755     Medline TA:  Prostate Cancer Prostatic Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  74-8     Citation Subset:  IM    
Affiliation:
Department of Urology, San Raffaele Hospital, Vita-Salute University, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies.
Next Document:  Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration.